Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome

Nephrology Dialysis Transplantation

Volumn 11, Issue 9, 1996, Pages 1810-1814

  Conlon, P J ^a   Brennan, D C ^b   Pfaf, W W ^c   Finn, W F ^d   Gehr, T ^e   Randal Bollinger, R ^a   Smith, S R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENCE RISK; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0029836834     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027673     Document Type: Article

References (26)

1. Moschowitz E. An acute pleomorphic anemia with hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Arch Intern Med 1925; 36: 89-93
2. Gasser C, Gauter E, Speck A, Siebermann RE, Oechslin R. Haemolytisch-Uramische syndrome: bilaterale Nierenrindennekrosen bei akuten erworbenen haemolytischen Anamien. Schwei: Med Wochenschr 1955; 85: 905-909
3. Remuzzi G, HUS and TTP: variable expression of a single entity. Kidney Int 1987; 32: 292-308
4. Milford DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H. Haemolytic uraemic syndrome in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1. Clinical and epidemiological aspects. Arch Dis Child 1990; 65: 716-721
5. Petitt RM. Thrombotic thrombocytopenic purpura; a thirty year review. Semin Thromb Hemost 1980; 6: 350-355
6. Bell WR, Hayden GB, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 1991; 325: 398-403
7. Conlon PJ, Howell DN, Macik G, Kovalik EC, Smith SR. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Nephrol Dial Transplant (in press)
8. Nissenson AR, Port FK. Outcome of end-stage renal disease in patients with rare causes of renal failure. III systemic/vascular disorders. Q J Med 1990; 74: 63-74
9. van den Berg-Wolf MG, Kootte AMM, Weening JJ. Recurrent hemolytic uremic syndrome in a renal transplant recipient and review of the Leiden experience. Transplantation 1987; 45:248-251
10. Bassani CE, Ferraris J, Gianantonio CA, Ruiz S, Ramirez J. Renal transplantation in patients with classical hemolytic-uremic syndrome. Pediatr Nephrol 1991; 5: 607-611
11. Eijgenraam FJ, Donckerwolcke RA, Monnens LAH, Proesmans W, Wolff ED, van Damme B. Renal transplantation in 20 children with hemolytic-uremic syndrome. Clin Nephrol 1990; 33: 87-93
12. Schwarz A, Krause P, Offermann G, Keller F. Recurrent and de nova renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991; 27: 524-531
13. Doutrelepont JM, Abramowicz D, Florquin S et al. Early recurrence of hemolytic uremic syndrome in a renal transplant recipient during prophylactic OKT3 therapy. Transplantation 1992; 53: 1378-1379
14. Hebert D, Sibley RK, Mauer SM. Recurrence of hemolytic uremic syndrome in renal transplant recipients. Kidney Int 1986; 30: S51-S58
15. Herbert D, Kim E, Sibley RK, Mauer MS. Post-transplantation outcome of patients with hemolytic-uremic syndrome: update. Pediatr Nephrol 1991; 5: 162-167
16. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic and infection by verocytoxin-producing Escherichia coli. J Infect Dis 1985; 151: 775-782
17. Croker BP, Salmon DR. Pathology of the renal allograft. In: Tisher CC, Brenner BM, ed. Renal Pathology. Lippincott, Philadelphia, 1989, 1518-1586
18. Hochstetler LA, Flanigan MJ, Lager DJ. Transplant-associated thrombotic microangiopathy: the role of IgG as initial therapy. Am J Kidney Dis 1994; 23: 444-450
19. The Canada Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325: 393-397
20. Buturovic J, Kandus A, Malovrh M, Bren A, Drinovec J. Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy. Transplant Proc 1990; 22: 1726-1727
21. Verpooten GA, Paulus GJ, Roels F, De Broe ME. De novo occurrence of hemolytic-uremic syndrome in a cyclosporinetreated renal allograft patient. Transplant Proc 1987; 19: 2943-2945
22. Chavers BM, Wells TG, Burke BA, Mauer SM. De novo hemolytic uremic syndrome following renal transplantation. Pediatr Nephrol 1989; 4: 62-64
23. Magalhaes RL, Braun WE, Straffon RA, Hoffman GC, Osborne G, Deodhar SD. Microangiopathic hemolytic anemia in renal allotransplantation. Am J Med 1975; 58: 862-868
24. Candinas O, Keusch G, Schlumpf R, Burger HR, Weder W, Largiader F. Prognostic factors of hemolytic uremic syndrome in renal allografts. Transplant Proc 1993; 25: 1041-1042
25. Lucca LJ, Ressurreicao F, Ferraz AS et al. De novo hemolytic uremia syndrome: a rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine. Transplant Proc 1992; 24: 3098-3099
26. Byrnes JJ, Moake JL. Thrombotic thrombocytopenic purpura and hemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol 1986; 15: 413-442